Trial intelligence / Profile preview

Rotarix Liquid vs Lyophilized Formulation in Infants

NCT02141204Phase 3Completed

Sponsor
GSK
Start
Feb 2019
Primary completion
Dec 2019
Modality
Live Attenuated Vaccines
Countries
1
01

Overview

A Phase 3 trial of rotavirus vaccine, live, oral in rotavirus gastroenteritis, sponsored by GSK. Started Feb 2019; status: completed.

02

Drugs

rotavirus vaccine, live, oral
03

Conditions

rotavirus gastroenteritis

Beyond the preview

Go deeper on NCT02141204.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02141204.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call